175 related articles for article (PubMed ID: 19383336)
1. Overexpression of SnoN/SkiL, amplified at the 3q26.2 locus, in ovarian cancers: a role in ovarian pathogenesis.
Nanjundan M; Cheng KW; Zhang F; Lahad J; Kuo WL; Schmandt R; Smith-McCune K; Fishman D; Gray JW; Mills GB
Mol Oncol; 2008 Aug; 2(2):164-81. PubMed ID: 19383336
[TBL] [Abstract][Full Text] [Related]
2. Phospholipid Scramblase 1, an interferon-regulated gene located at 3q23, is regulated by SnoN/SkiL in ovarian cancer cells.
Kodigepalli KM; Anur P; Spellman P; Sims PJ; Nanjundan M
Mol Cancer; 2013 Apr; 12():32. PubMed ID: 23621864
[TBL] [Abstract][Full Text] [Related]
3. SnoN/SkiL expression is modulated via arsenic trioxide-induced activation of the PI3K/AKT pathway in ovarian cancer cells.
Kodigepalli KM; Dutta PS; Bauckman KA; Nanjundan M
FEBS Lett; 2013 Jan; 587(1):5-16. PubMed ID: 23178716
[TBL] [Abstract][Full Text] [Related]
4. Systematic interrogation of 3q26 identifies TLOC1 and SKIL as cancer drivers.
Hagerstrand D; Tong A; Schumacher SE; Ilic N; Shen RR; Cheung HW; Vazquez F; Shrestha Y; Kim SY; Giacomelli AO; Rosenbluh J; Schinzel AC; Spardy NA; Barbie DA; Mermel CH; Weir BA; Garraway LA; Tamayo P; Mesirov JP; Beroukhim R; Hahn WC
Cancer Discov; 2013 Sep; 3(9):1044-57. PubMed ID: 23764425
[TBL] [Abstract][Full Text] [Related]
5. Arsenic trioxide induces a beclin-1-independent autophagic pathway via modulation of SnoN/SkiL expression in ovarian carcinoma cells.
Smith DM; Patel S; Raffoul F; Haller E; Mills GB; Nanjundan M
Cell Death Differ; 2010 Dec; 17(12):1867-81. PubMed ID: 20508647
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-β/SMAD Target gene SKIL is negatively regulated by the transcriptional cofactor complex SNON-SMAD4.
Tecalco-Cruz AC; Sosa-Garrocho M; Vázquez-Victorio G; Ortiz-García L; Domínguez-Hüttinger E; Macías-Silva M
J Biol Chem; 2012 Aug; 287(32):26764-76. PubMed ID: 22674574
[TBL] [Abstract][Full Text] [Related]
7. Loss of c-myc repression coincides with ovarian cancer resistance to transforming growth factor beta growth arrest independent of transforming growth factor beta/Smad signaling.
Baldwin RL; Tran H; Karlan BY
Cancer Res; 2003 Mar; 63(6):1413-9. PubMed ID: 12649207
[TBL] [Abstract][Full Text] [Related]
8. Expression profiles of SnoN in normal and cancerous human tissues support its tumor suppressor role in human cancer.
Jahchan NS; Ouyang G; Luo K
PLoS One; 2013; 8(2):e55794. PubMed ID: 23418461
[TBL] [Abstract][Full Text] [Related]
9. SnoN overexpression is predictive of poor survival in patients with esophageal squamous cell carcinoma.
Akagi I; Miyashita M; Makino H; Nomura T; Hagiwara N; Takahashi K; Cho K; Mishima T; Takizawa T; Tajiri T
Ann Surg Oncol; 2008 Oct; 15(10):2965-75. PubMed ID: 18612694
[TBL] [Abstract][Full Text] [Related]
10. SnoN is a cell type-specific mediator of transforming growth factor-beta responses.
Sarker KP; Wilson SM; Bonni S
J Biol Chem; 2005 Apr; 280(13):13037-46. PubMed ID: 15677458
[TBL] [Abstract][Full Text] [Related]
11. Amplification of MDS1/EVI1 and EVI1, located in the 3q26.2 amplicon, is associated with favorable patient prognosis in ovarian cancer.
Nanjundan M; Nakayama Y; Cheng KW; Lahad J; Liu J; Lu K; Kuo WL; Smith-McCune K; Fishman D; Gray JW; Mills GB
Cancer Res; 2007 Apr; 67(7):3074-84. PubMed ID: 17409414
[TBL] [Abstract][Full Text] [Related]
12. SnoN/SKIL modulates proliferation through control of hsa-miR-720 transcription in esophageal cancer cells.
Shinozuka E; Miyashita M; Mizuguchi Y; Akagi I; Kikuchi K; Makino H; Matsutani T; Hagiwara N; Nomura T; Uchida E; Takizawa T
Biochem Biophys Res Commun; 2013 Jan; 430(1):101-6. PubMed ID: 23154181
[TBL] [Abstract][Full Text] [Related]
13. The downregulation of SnoN expression in human renal proximal tubule epithelial cells under high-glucose conditions is mediated by an increase in Smurf2 expression through TGF-β1 signaling.
Li X; Diao Z; Ding J; Liu R; Wang L; Huang W; Liu W
Int J Mol Med; 2016 Feb; 37(2):415-22. PubMed ID: 26743567
[TBL] [Abstract][Full Text] [Related]
14. SnoN/SkiL, a TGFβ signaling mediator: a participant in autophagy induced by arsenic trioxide.
Raffoul F; Campla C; Nanjundan M
Autophagy; 2010 Oct; 6(7):955-7. PubMed ID: 20699661
[TBL] [Abstract][Full Text] [Related]
15. Molecular basis for the cell type specific induction of SnoN expression by hepatocyte growth factor.
Tan R; Zhang X; Yang J; Li Y; Liu Y
J Am Soc Nephrol; 2007 Aug; 18(8):2340-9. PubMed ID: 17625116
[TBL] [Abstract][Full Text] [Related]
16. SnoN: bridging neurobiology and cancer biology.
Pot I; Ikeuchi Y; Bonni A; Bonni S
Curr Mol Med; 2010 Oct; 10(7):667-73. PubMed ID: 20712586
[TBL] [Abstract][Full Text] [Related]
17. Dual role of SnoN in mammalian tumorigenesis.
Zhu Q; Krakowski AR; Dunham EE; Wang L; Bandyopadhyay A; Berdeaux R; Martin GS; Sun L; Luo K
Mol Cell Biol; 2007 Jan; 27(1):324-39. PubMed ID: 17074815
[TBL] [Abstract][Full Text] [Related]
18. The role of SnoN in transforming growth factor beta1-induced expression of metalloprotease-disintegrin ADAM12.
Solomon E; Li H; Duhachek Muggy S; Syta E; Zolkiewska A
J Biol Chem; 2010 Jul; 285(29):21969-77. PubMed ID: 20457602
[TBL] [Abstract][Full Text] [Related]
19. The transforming activity of Ski and SnoN is dependent on their ability to repress the activity of Smad proteins.
He J; Tegen SB; Krawitz AR; Martin GS; Luo K
J Biol Chem; 2003 Aug; 278(33):30540-7. PubMed ID: 12764135
[TBL] [Abstract][Full Text] [Related]
20. Cytoplasmic SnoN in normal tissues and nonmalignant cells antagonizes TGF-beta signaling by sequestration of the Smad proteins.
Krakowski AR; Laboureau J; Mauviel A; Bissell MJ; Luo K
Proc Natl Acad Sci U S A; 2005 Aug; 102(35):12437-42. PubMed ID: 16109768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]